Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)

NCT00202891 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No further local interest in pursuing the study.

Conditions

Pyoderma

Interventions

DRUG: sisomicin

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]